Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × GRN163L peptide × Clear all

NCT01242930 2016-05-12

Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell